Back to Search
MARK KAPLAN, MD
MD
Allergy & Immunology Physician
NPI: 1861591661Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
PMID 19114458·Pediatrics·2009
4-observational
The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.
PMID 19177059·J Perinatol·2009
5-case
Early intervention of negative pressure wound therapy using Vacuum-Assisted Closure in trauma patients: impact on hospital length of stay and cost.
PMID 19247014·Adv Skin Wound Care·2009
8-other
Visual screening versus transcutaneous bilirubinometry for predischarge jaundice assessment.
PMID 18460107·Acta Paediatr·2008
4-observational
Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate.
PMID 18379570·J Perinatol·2008
5-case
(TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates.
PMID 18043502·Pediatr Res·2008
4-observational
Intravascular uptake during fluoroscopically guided cervical interlaminar steroid injection at C6-7: a case report.
PMID 18295636·Arch Phys Med Rehabil·2008
8-other
Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus.
PMID 18322551·J Perinatol·2008
8-other
Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience.
PMID 17382121·J Pediatr·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 36100 N BROOKSIDE DR STE 203
GURNEE, IL 60031 - Phone
- (847) 855-1570
Quick Facts
- NPI
- 1861591661
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile